Press Releases :: Avalo Therapeutics, Inc. (AVTX)

Jul 1, 2019 6:30 am EDT

Cerecor Announces Positive Final Results of CERC-301 in the Treatment of Neurogenic Orthostatic Hypotension (OH)

Jun 28, 2019 6:30 am EDT

Cerecor Added to Russell 3000® Index

Jun 12, 2019 4:05 pm EDT

Cerecor Appoints Keith Schmidt to its Board of Directors

Jun 11, 2019 1:00 pm EDT

Cerecor Set to Join Russell 3000® Index

May 9, 2019 4:05 pm EDT

Cerecor Reports First Quarter 2019 Results

Apr 29, 2019 6:30 am EDT

Cerecor Announces Positive Phase I Safety Data for CERC-801 in Healthy Volunteers

Apr 15, 2019 6:30 am EDT

Cerecor Announces Positive Interim Results of CERC-301 in the Treatment of Neurogenic Orthostatic Hypotension (nOH)

Apr 11, 2019 6:30 am EDT

Cerecor Announces Leadership Changes

Mar 18, 2019 4:05 pm EDT

Cerecor Reports Fourth Quarter and Full Year 2018 Results

Mar 11, 2019 9:15 am EDT

Cerecor Announces Closing of $10.0 Million Bought Deal of Common Stock